Progression of localised Wilms' tumour during preoperative chemotherapy is an independent prognostic factor: A report from the SIOP 93-01 nephroblastoma trial and study

European Journal of Cancer

Volumn 43, Issue 1, 2007, Pages 131-136

  Øra, Ingrid ^a,d   van Tinteren, Harm ^b   Bergeron, Christophe ^c   de Kraker, Jan ^d  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b Integraal Kankercentrum Amsterdam   (Netherlands)

^c CENTRE LÉON BÉRARD   (France)

^d EMMA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

Clinical tumour response; Event free survival; Histopathological risk group; Nephroblastoma; Overall survival; Preoperative chemotherapy; Prognostic factor; Tumour response evaluation; Wilms' tumour

Indexed keywords

DACTINOMYCIN; EPIRUBICIN; VINCRISTINE;

ADOLESCENT; ADVANCED CANCER; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CHILD; CLINICAL TRIAL; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; FEMALE; HIGH RISK PATIENT; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEPHROBLASTOMA; OVERALL SURVIVAL; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROGNOSIS; TUMOR GROWTH; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; FEMALE; HUMANS; INFANT; KIDNEY NEOPLASMS; MALE; NEOPLASM RECURRENCE, LOCAL; PREOPERATIVE CARE; PROGNOSIS; WILMS TUMOR;

EID: 33845976672     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2006.08.033     Document Type: Article

References (19)

1. Lemerle J., Voute P.A., Tournade M.F., et al. Preoperative versus postoperative radiotherapy, single versus multiple courses of actinomycin D, in the treatment of Wilms' tumor. Preliminary results of a controlled clinical trial conducted by the International Society of Paediatric Oncology (S.I.O.P.). Cancer 38 (1976) 47-654
2. Lemerle J., Voute P.A., Tournade M.F., et al. Effectiveness of preoperative chemotherapy in Wilms' tumor: results of an International Society of Paediatric Oncology (SIOP) clinical trial. J Clin Oncol 1 (1983) 604-609
3. Tournade M.F., Com-Nougue C., Voute P.A., et al. Results of the Sixth International Society of Pediatric Oncology Wilms' Tumor Trial and Study: a risk-adapted therapeutic approach in Wilms' tumor. J Clin Oncol 11 (1993) 1014-1023
4. Tournade M.F., Com-Nougue C., de Kraker J., et al. Optimal duration of preoperative therapy in unilateral and nonmetastatic Wilms' tumor in children older than 6 months: results of the Ninth International Society of Pediatric Oncology Wilms' Tumor Trial and Study. J Clin Oncol 19 (2001) 488-500
5. Green D.M., D'Angio G.J., Beckwith J.B., et al. Wilms tumor. CA Cancer J Clin 46 (1996) 46-63
6. Neville H.L., and Ritchey M.L. Wilms' tumor. Overview of National Wilms' Tumor Study Group results. Urol Clin North Am 27 (2000) 434-442
7. Green D.M. The treatment of stages I-IV favorable histology Wilms' tumor. J Clin Oncol 22 (2004) 1366-1372
8. Pritchard-Jones K., and Pritchard J. Success of clinical trials in childhood Wilms' tumour around the world. Lancet 364 (2004) 1468-1470
9. Wu H.Y., Snyder III H.M., and D'Angio G.J. Wilms' tumor management. Curr Opin Urol 15 (2005) 273-276
10. de Kraker J., Graf N., van Tinteren H., et al. Reduction of postoperative chemotherapy in children with stage I intermediate-risk and anaplastic Wilms' tumour (SIOP 93-01 trial): a randomised controlled trial. Lancet 364 (2004) 1229-1235
11. Vujanic G.M., Sandstedt B., Harms D., Kelsey A., Leuschner I., and de Kraker J. Revised International Society of Paediatric Oncology (SIOP) working classification of renal tumors of childhood. Med Pediatr Oncol 38 (2002) 79-82
12. Godzinski J., Tournade M.F., deKraker J., et al. Rarity of surgical complications after postchemotherapy nephrectomy for nephroblastoma. Experience of the International Society of Paediatric Oncology-Trial and Study "SIOP-9. International Society of Paediatric Oncology Nephroblastoma Trial and Study Committee. Eur J Pediatr Surg 8 (1998) 83-86
13. Godzinski J., Weirich A., Tournade M.F., et al. Primary nephrectomy for emergency: a rare event in the International Society of Paediatric Oncology Nephroblastoma Trial and Study no. 9. Eur J Pediatr Surg 11 (2001) 36-39
14. Weirich A., Ludwig R., Graf N., et al. Survival in nephroblastoma treated according to the trial and study SIOP-9/GPOH with respect to relapse and morbidity. Ann Oncol 15 (2004) 808-820
15. Bacci G., Longhi A., Versari M., Mercuri M., Briccoli A., and Picci P. Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution. Cancer 106 (2006) 1154-1161
16. Paulussen M., Ahrens S., Dunst J., et al. Localized Ewing tumor of bone: final results of the cooperative Ewing's Sarcoma Study CESS 86. J Clin Oncol 19 (2001) 1818-1829
17. Anderson J., Slater O., McHugh K., Duffy P., and Pritchard J. Response without shrinkage in bilateral Wilms tumor: significance of rhabdomyomatous histology. J Pediatr Hematol Oncol 24 (2002) 31-34
18. Maes P., DeLemarre J., de Kraker J., and Ninane J. Fetal rhabdomyomatous nephroblastoma: a tumour of good prognosis but resistant to chemotherapy. Eur J Cancer 35 (1999) 1356-1360
19. Boccon-Gibod L., Rey A., Sandstedt B., et al. Complete necrosis induced by preoperative chemotherapy in Wilms tumor as an indicator of low risk: report of the international society of paediatric oncology (SIOP) nephroblastoma trial and study 9. Med Pediatr Oncol 34 (2000) 183-190